VR Logo

Aspira Pathlab & Diagnostics: Financial Results For The Year Ended March 31 2022


Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform that Board of Directors of the Company in their meeting held today i.e. May 28 2022 has inter-alia considered and approved the Audited Financial Results for the year ended on March 31 2022.Please find attached:Audited Financial Results for the year ended on March 31 2022 along with statement of Assets & Liabilities and Cash Flow Statement Auditors Report and Declaration about unmodified opinion in audit report.

Click here to view PDF